NeuroX1
Austin
About NeuroX1
NeuroX1 is a computational drug design startup building a platform to identify drivers of neurodegenerative/neurological diseases then using Chiron, a propritary generative chemistry platform, designs novel compounds for those diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.0M
- Funding stage: Seed
- Last round: Seed (Mar 2024)
- Website: neurox1.com
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biopharma, Biotechnology, Generative AI, Life Science
Social Profiles
Canonical: https://fsome.com/organization/neurox1-93390 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.